Across TCGA pan-cancer cohorts, MIR1180 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1180’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR1180 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR1180 is over-expressed in tumor, although a few such as BRCA and UCEC show the opposite, repressed pattern.

BRCA, PAAD, and UCEC are the cancer types where MIR1180 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1180 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	−0.174	.024	4	view →
PAAD	Female	All	+1.685	.022	2	view →
UCEC	All	All	−0.381	.042	2	view →
LIHC	All	All	+0.144	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1180 RNA expression & survival · all MIR1180 data types